21. Reference
Cadeddu JA, Elashry OM, Snyder O, Schulam P, Moore RG, Loughlin KR et al. Effect of laparoscopic
pelvic lymph node dissection on the natural history of D1 (T1-3, N1-3, M0) prostate cancer. Urology
1997;50:391-4.
Fergany A, Kupelian PA, Levin HS, Zippe CD, Reddy C, Klein EA. No difference in biochemical failure
rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients.
Urology 2000;56:92-5.
Freid RM, Siegel D, Smith AD, Weiss GH. Lymphoceles after laparoscopic pelvic node dissection.
Urology 1998;51:131-4.
Kava BR, Dalbagni G, Conlon KC, Russo P. Results of laparoscopic pelvic lymphadenectomy in
patients at high risk for nodal metastases from prostate cancer. Ann Surg Oncol 1998;5:173-80.
Lund GO, Winfield HN, Donovan JF, See WA, Loening SA, Williams RD. Laparoscopic pelvic lymph
node dissection following definitive radiotherapy for carcinoma of the prostate. J Urol 1997;157:548-
51.
Schuessler WW, Vancaillie TG, Reich H, Griffith DP. Transperitoneal endosurgical lymphadenectomy
in patients with localized prostate cancer. J Urol 1991;145:988-91.
Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer:
comparison of the extended and modified techniques. J Urol 1997;158:1891-4.
Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis for
pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.
J Urol 1996;156:1969-71. |